Morgan Stanley Initiates Coverage On Elevance Health with Overweight Rating, Announces Price Target of $643
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has initiated coverage on Elevance Health (NYSE:ELV) with an Overweight rating and set a price target of $643.
June 24, 2024 | 9:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has initiated coverage on Elevance Health with an Overweight rating and set a price target of $643.
An Overweight rating from a major financial institution like Morgan Stanley typically indicates a positive outlook on the stock. The price target of $643 suggests significant upside potential, which is likely to attract investor interest and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100